A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
Clinical trial NCT03292133 · TERMINATED
Trial details
- NCT number
- NCT03292133
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2021-12-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.